Table 2 Signs of risk of preterm birth and ACS use among mothers of small babies (stillbirths and livebirths) by site during the trial period
Latin America | South Asia | sub-Saharan Africa | |||||
|---|---|---|---|---|---|---|---|
Argentina | Chimaltenango, Guatemala | India, Belgaum | India, Nagpur | Thatta, Pakistan | Kafue, Zambia | W. Provence, Kenya | |
Women with small (<5th %ile) babies and non-missing, N | 142 | 181 | 808 | 336 | 816 | 243 | 199 |
Antepartum conditions reporteda | |||||||
Threatened preterm labor | 21 (14.8) | 76 (42.0) | 507 (62.7) | 115 (34.2) | 231 (28.3) | 83 (34.2) | 38 (19.1) |
Preterm PROM | 17 (12.0) | 33 (18.2) | 127 (15.7) | 31 (9.2) | 299 (36.6) | 42 (17.3) | 22 (11.1) |
Hypertensive disorders | 20 (14.1) | 24 (13.3) | 96 (11.9) | 10 (3.0) | 267 (32.7) | 4 (1.6) | 13 (6.5) |
Hemorrhage | 8 (5.6) | 5 (2.8) | 54 (6.7) | 6 (1.8) | 155 (19.0) | 31 (12.8) | 34 (17.1) |
Chorioamnionitis or fever | 4 (2.8) | 15 (8.3) | 32 (4.0) | 1 (0.3) | 307 (37.6) | 1 (0.4) | 13 (6.5) |
Other antepartum condition | 14 (9.9) | 2 (1.1) | 46 (5.7) | 11 (3.3) | 79 (9.7) | 7 (2.9) | 3 (1.5) |
No condition reported | 73 (51.4) | 85 (47.0) | 208 (25.7) | 196 (58.3) | 157 (19.2) | 122 (50.2) | 113 (56.8) |
ACS administered prior to deliverya | 61 (44.2) | 21 (12.0) | 89 (11.0) | 15 (4.7) | 29 (3.6) | 8 (3.4) | 4 (2.0) |
Dexamethasone | 41 (29.7) | 19 (10.9) | 48 (5.9) | 6 (1.9) | 18 (2.2) | 7 (3.0) | 0 (0.0) |
Betamethasone | 17 (12.3) | 0 (0.0) | 28 (3.5) | 4 (1.3) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Other steroids | 0 (0.0) | 0 (0.0) | 3 (0.4) | 0 (0.0) | 1 (0.1) | 0 (0.0) | 0 (0.0) |
Full course | 25 (18.1) | 3 (1.7)) | 19 (2.4) | 0 (0.0) | 3 (0.4) | 6 (2.5) | 0 (0.0) |